Microbial strains and process for the manufacture of biomaterials
View Patent ↗DNA constructs and genetically engineered microbial strains constructed using these DNA constructs, which produce a nuclease enzyme with specificity for DNA and/or RNA, are provided. These strains secrete nuclease into the periplasm or growth medium in an amount effective to enhance productivity and/or recovery of polymer, and are particularly suited for use in high cell density fermentation processes. These constructs are useful for modifying microbial strains to improve production and recovery processes for polymers such as intracellular proteins, such as enzymes, growth factors, and cytokines; for producing polyhydroxyalkanoates; and for producing extracellular polysaccharides, such as xanthan gum, alginates, gellan gum, zooglan, hyaluronic acid and microbial cellulose.
1. A bacterial strain producing polyhydroxyalkanoates wherein the bacterial strain is selected from the group consisting of Ralstonia eutropha, Pseudomonas putida and Escherichia coli and is genetically modified to express a heterologous nuclease gene integrated into the chromosome of the bacterial strain, wherein the nuclease is secreted into the periplasmic space and released when the bacteria is lysed in an amount effective to degrade in less than 24 hours at least 95% of all of the nucleic acid released following lysis of the cells.
2. The bacterial strain of claim 1 which produces a polyhydroxyalkanoate to levels of at least 40% of its dry cell weight.
3. The bacterial strain of claim 1 for use in an aqueous process to manufacture poly(3-hydroxyalkanoate) granule suspension which is essentially free of nucleic acids.
4. The bacterial strain of claim 1 wherein the nuclease gene is a heterologous gene obtained from an organism other than the bacterial strain.
5. The bacterial strain producing polyhydroxyalkanoates of claim 1 , wherein the bacterial strain is selected from the group consisting of Ralstonia eutropha, Pseudomonas putida and Escherichia coli and is genetically modified to express a heterologous nuclease gene integrated into the chromosome of the bacterial host, wherein the nuclease is secreted into the periplasmic space and released when the bacteria is lysed in an amount effective to degrade in less than 24 hours at least 95% of all of the nucleic acid released following lysis of the cells in a bacterial cell culture having a density of at least 50 g/l so that recovery of product is enhanced.
6. A fermentation process comprising
adding to a growth medium a bacterial strain producing polyhydroxyalkanoates, wherein the bacterial strain is selected from the group consisting of Ralstonia eutropha, Pseudomonas putida and Escherichia coli and is genetically modified to express a heterologous nuclease gene integrated into the chromosome of the bacterial host, wherein the nuclease is secreted into the periplasmic space and released when the bacteria is lysed in an amount effective to degrade in less than 24 hours at least 95% of all of the nucleic acid released following lysis of the cells.
7. The process of claim 6 , wherein the bacterial strain is grown to cell densities of at least 50 g/l.
8. The process of claim 7 further comprising growing the bacterial strain to produce levels of at least 40% of its dry cell weight.
9. The process of claim 6 further comprising lysing the cells.
10. The process of claim 8 further comprising using an aqueous process to manufacture a poly(3-hydroxyalkanoates) granule suspension which is essentially free of nucleic acids.